Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Systematic review and external validation of prediction models based on symptoms and biomarkers for identifying endoscopic activity in Crohn's disease.

Brand EC, Elias SG, Minderhoud IM, van der Veen JJ, Baert FJ, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Pariente B, Pierik MJ, van der Woude CJ, D'Haens GRAM, Vermeire S, Oldenburg B; Dutch Initiative on Crohn and Colitis (ICC).

Clin Gastroenterol Hepatol. 2019 Dec 24. pii: S1542-3565(19)31493-4. doi: 10.1016/j.cgh.2019.12.014. [Epub ahead of print] Review.

PMID:
31881273
2.

Diagnosis and outcome of oesophageal Crohn's disease.

Vale Rodrigues R, Sladek M, Katsanos K, van der Woude CJ, Wei J, Vavricka SR, Teich N, Ellul P, Savarino E, Chaparro M, Beaton D, Oliveira AM, Fragaki M, Shitrit AB, Ramos L, Karmiris K; ECCO CONFER investigators.

J Crohns Colitis. 2019 Dec 14. pii: jjz201. doi: 10.1093/ecco-jcc/jjz201. [Epub ahead of print]

PMID:
31837220
3.

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.

Moens A, van der Woude CJ, Julsgaard M, Humblet E, Sheridan J, Baumgart DC, Gilletta De Saint-Joseph C, Nancey S, Rahier JF, Bossuyt P, Cremer A, Dewit S, Eriksson C, Hoentjen F, Krause T, Louis E, Macken E, Milenkovic Z, Nijs J, Posen A, Van Hootegem A, Van Moerkercke W, Vermeire S, Bar-Gil Shitrit A, Ferrante M.

Aliment Pharmacol Ther. 2020 Jan;51(1):129-138. doi: 10.1111/apt.15539. Epub 2019 Nov 6.

PMID:
31692017
4.

Health-related quality of life in the first 5 years of the children born to mothers with IBD does not differ from children born to healthy mothers.

van der Giessen J, Wieringa JW, Kanis SL, van der Woude CJ.

J Psychosom Res. 2019 Dec;127:109840. doi: 10.1016/j.jpsychores.2019.109840. Epub 2019 Oct 25.

PMID:
31677548
5.

Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab.

Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, Oldenburg B, de Boer NK, Löwenberg M, Srivastava N, Bodelier AGL, West RL, Jansen JM, de Vries AC, Haans JJL, de Jong DJ, Pierik MJ, Hoentjen F.

Clin Pharmacol Ther. 2019 Nov 2. doi: 10.1002/cpt.1712. [Epub ahead of print]

PMID:
31677154
6.

The pre- and post-authorisation data published by the European Medicines Agency on the use of Biologics during pregnancy and lactation.

Ghalandari N, Dolhain RJEM, Hazes JMW, Siezen CLE, van der Laan JW, Crijns HJ, van Puijenbroek EP, van der Woude CJ.

Br J Clin Pharmacol. 2019 Oct 21. doi: 10.1111/bcp.14145. [Epub ahead of print]

PMID:
31633830
7.

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.

Deuring JJ, Li M, Cao W, Chen S, Wang W, de Haar C, van der Woude CJ, Peppelenbosch M.

PLoS One. 2019 Oct 3;14(10):e0221924. doi: 10.1371/journal.pone.0221924. eCollection 2019.

8.

Isolated ileal blind loop inflammation after intestinal resection with ileocolonic anastomosis in Crohn's disease: an often neglected endoscopic finding with an unfavorable outcome.

Beelen EMJ, de Vries AC, Bodelier AG, Moolenaar J, Schouten WR, van der Woude CJ.

Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1370-1375. doi: 10.1097/MEG.0000000000001551.

PMID:
31567617
9.

Longitudinal trajectory of fatigue with initiation of biologic therapy in inflammatory bowel diseases: A prospective cohort study.

Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van der Woude CJ, Ananthakrishnan AN.

J Crohns Colitis. 2019 Aug 26. pii: jjz148. doi: 10.1093/ecco-jcc/jjz148. [Epub ahead of print]

PMID:
31504365
10.

Intestinal resection rates in Crohn's disease decline across two different epidemiological areas: a consistent observation not merely due to introduction of anti-TNFα.

Beelen EMJ, van der Woude CJ, de Vries AC.

Gut. 2019 Aug 14. pii: gutjnl-2019-319321. doi: 10.1136/gutjnl-2019-319321. [Epub ahead of print] No abstract available.

11.

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.

Kreijne JE, de Veer RC, de Boer NK, Dijkstra G, West R, Moorsel SAW, de Jong DJ, van der Woude CJ, de Vries AC; of the Dutch Initiative on Crohn, Colitis (ICC).

Aliment Pharmacol Ther. 2019 Aug;50(4):407-415. doi: 10.1111/apt.15402.

PMID:
31359480
12.

Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease".

Pauwels RWM, de Vries AC, van der Woude CJ.

Inflamm Bowel Dis. 2019 Apr 11;25(5):e59. doi: 10.1093/ibd/izy273. No abstract available.

PMID:
31222304
13.

Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.

Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Löwenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F.

J Crohns Colitis. 2020 Jan 1;14(1):33-45. doi: 10.1093/ecco-jcc/jjz119.

PMID:
31219157
14.

Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.

Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE.

J Crohns Colitis. 2020 Jan 1;14(1):64-70. doi: 10.1093/ecco-jcc/jjz116.

15.

Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease: A Nationwide Cohort Study.

Beelen EMJ, van der Woude CJ, Pierik MJ, Hoentjen F, de Boer NK, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Dijkstra G, Bruggink AH, Erler NS, Schouten WR, de Vries AC; Dutch Initiative on Crohnʼs and Colitis (ICC).

Ann Surg. 2019 Jun 10. doi: 10.1097/SLA.0000000000003395. [Epub ahead of print]

PMID:
31188225
16.

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.

Löwenberg M, Vermeire S, Mostafavi N, Hoentjen F, Franchimont D, Bossuyt P, Hindryckx P, Rispens T, de Vries A, van der Woude CJ, Berends S, Ambarus CA, Mathot R, Clasquin E, Baert F, D'Haens G.

Gastroenterology. 2019 Oct;157(4):997-1006.e6. doi: 10.1053/j.gastro.2019.05.067. Epub 2019 Jun 5.

PMID:
31175865
17.

Modulation of cytokine patterns and microbiome during pregnancy in IBD.

van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, Louzoun Y, Peppelenbosch MP, van der Woude CJ, Koren O, Fuhler GM.

Gut. 2019 Jun 5. pii: gutjnl-2019-318263. doi: 10.1136/gutjnl-2019-318263. [Epub ahead of print]

18.

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.

Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D'Haens G, Vermeire S, Gils A.

Clin Gastroenterol Hepatol. 2019 May 22. pii: S1542-3565(19)30551-8. doi: 10.1016/j.cgh.2019.05.029. [Epub ahead of print]

PMID:
31128336
19.

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C.

Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14.

20.

Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial.

van den Brink G, Stapersma L, Bom AS, Rizopolous D, van der Woude CJ, Stuyt RJL, Hendriks DM, van der Burg JAT, Beukers R, Korpershoek TA, Theuns-Valks SDM, Utens EMWJ, Escher JC.

Inflamm Bowel Dis. 2019 Nov 14;25(12):1945-1956. doi: 10.1093/ibd/izz073.

PMID:
31050763
21.

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.

Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC).

Aliment Pharmacol Ther. 2019 May;49(10):1293-1300. doi: 10.1111/apt.15229. Epub 2019 Mar 25.

22.

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease.

van der Giessen J, Huang VW, van der Woude CJ, Fuhler GM.

Clin Transl Gastroenterol. 2019 Mar;10(3):e00009. doi: 10.14309/ctg.0000000000000009.

23.

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models.

van der Giessen J, van der Woude CJ, Peppelenbosch MP, Fuhler GM.

Cells. 2019 Mar 19;8(3). pii: E261. doi: 10.3390/cells8030261.

24.

Pregnancy, psychiatry and IBD: multidisciplinary care is crucial.

van der Woude CJ, Shitrit AB.

Nat Rev Gastroenterol Hepatol. 2019 May;16(5):265-266. doi: 10.1038/s41575-019-0135-9. No abstract available.

PMID:
30890814
25.

Epithelial endoplasmic reticulum stress orchestrates a protective IgA response.

Grootjans J, Krupka N, Hosomi S, Matute JD, Hanley T, Saveljeva S, Gensollen T, Heijmans J, Li H, Limenitakis JP, Ganal-Vonarburg SC, Suo S, Luoma AM, Shimodaira Y, Duan J, Shih DQ, Conner ME, Glickman JN, Fuhler GM, Palm NW, de Zoete MR, van der Woude CJ, Yuan GC, Wucherpfennig KW, Targan SR, Rosenstiel P, Flavell RA, McCoy KD, Macpherson AJ, Kaser A, Blumberg RS.

Science. 2019 Mar 1;363(6430):993-998. doi: 10.1126/science.aat7186.

26.

Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study.

van den Brink G, van Gaalen MAC, de Ridder L, van der Woude CJ, Escher JC.

J Crohns Colitis. 2019 Sep 19;13(9):1163-1172. doi: 10.1093/ecco-jcc/jjz044.

PMID:
30766997
27.

Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.

Goetgebuer RL, van der Woude CJ, de Ridder L, Doukas M, de Vries AC.

Int J Colorectal Dis. 2019 May;34(5):923-926. doi: 10.1007/s00384-019-03257-7. Epub 2019 Feb 9.

PMID:
30739187
28.

Fatigue in IBD: epidemiology, pathophysiology and management.

Borren NZ, van der Woude CJ, Ananthakrishnan AN.

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):247-259. doi: 10.1038/s41575-018-0091-9. Review.

PMID:
30531816
29.

Cholecystectomy Risk in Crohn's Disease Patients After Ileal Resection: a Long-term Nationwide Cohort Study.

Goet JC, Beelen EMJ, Biermann KE, Gijsbers AH, Schouten WR, van der Woude CJ, de Vries AC.

J Gastrointest Surg. 2019 Sep;23(9):1840-1847. doi: 10.1007/s11605-018-4028-y. Epub 2018 Nov 8.

30.

Editorial: The Effect of Thiopurines on Offspring.

Wieringa JW, van der Woude CJ.

J Crohns Colitis. 2019 Jan 1;13(1):1-2. doi: 10.1093/ecco-jcc/jjy134. No abstract available.

PMID:
30272119
31.

Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system.

Wieringa JW, Driessen GJ, Van Der Woude CJ.

Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):811-818. doi: 10.1080/17474124.2018.1496820. Epub 2018 Jul 12. Review.

PMID:
29972674
32.

Self-efficacy did not predict the outcome of the transition to adult care in adolescents with inflammatory bowel disease.

van den Brink G, van Gaalen MAC, Zijlstra M, de Ridder L, van der Woude CJ, Escher JC.

Acta Paediatr. 2019 Feb;108(2):333-338. doi: 10.1111/apa.14471. Epub 2018 Jul 10.

33.

TNF-α exerts potent anti-rotavirus effects via the activation of classical NF-κB pathway.

Hakim MS, Ding S, Chen S, Yin Y, Su J, van der Woude CJ, Fuhler GM, Peppelenbosch MP, Pan Q, Wang W.

Virus Res. 2018 Jul 15;253:28-37. doi: 10.1016/j.virusres.2018.05.022. Epub 2018 May 31.

34.

Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type.

Kanis SL, de Lima-Karagiannis A, van der Ent C, Rizopoulos D, van der Woude CJ.

J Crohns Colitis. 2018 Jul 30;12(8):939-947. doi: 10.1093/ecco-jcc/jjy058.

PMID:
29771301
35.

Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero.

de Lima A, Kanis SL, Escher JC, van der Woude CJ.

J Crohns Colitis. 2018 Jul 30;12(8):948-953. doi: 10.1093/ecco-jcc/jjy053.

PMID:
29726943
36.

Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.

Ten Hove JR, Shah SC, Shaffer SR, Bernstein CN, Castaneda D, Palmela C, Mooiweer E, Elman J, Kumar A, Glass J, Axelrad J, Ullman TA, Colombel JF, Torres J, van Bodegraven AA, Hoentjen F, Jansen JM, de Jong ME, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Itzkowitz SH, Oldenburg B.

Gut. 2019 Apr;68(4):615-622. doi: 10.1136/gutjnl-2017-315440. Epub 2018 May 2.

PMID:
29720408
37.

Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.

Meijer B, Mulder CJJ, Bouma G, Ponsioen CY, van der Woude CJ, van der Meulen AE, Wintjens DSJ, Dijkstra G, Hoentjen F, Oldenburg B, van Bodegraven AA, de Boer NKH; Dutch Initiative on Crohn and Colitis (ICC) and Parelsnoer Institute.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1558-1565. doi: 10.1093/ibd/izy047.

PMID:
29668998
38.

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

Lie MRKL, van der Giessen J, Fuhler GM, de Lima A, Peppelenbosch MP, van der Ent C, van der Woude CJ.

J Transl Med. 2018 Mar 9;16(1):55. doi: 10.1186/s12967-018-1427-5.

39.

Correlating Fecal Calprotectin With Hemoglobin Levels Within 1 Sample.

Fuhler GM, van der Giessen J, van der Woude CJ, Peppelenbosch MP.

Inflamm Bowel Dis. 2018 Feb 15;24(3):663. doi: 10.1093/ibd/izx028. No abstract available.

PMID:
29462378
40.

High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.

Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1106-1113.e3. doi: 10.1016/j.cgh.2018.01.023. Epub 2018 Mar 15.

PMID:
29378311
41.

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Visschedijk MC, Spekhorst LM, Cheng SC, van Loo ES, Jansen BHD, Blokzijl T, Kil H, de Jong DJ, Pierik M, Maljaars JPWJ, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Nieuwenhuijs VB, Imhann F, van Sommeren S, Alberts R, Xavier RJ, Dijkstra G, Nico Faber K, Aldaz CM, Weersma RK, Festen EAM.

J Crohns Colitis. 2018 Apr 27;12(5):582-588. doi: 10.1093/ecco-jcc/jjy001.

PMID:
29361163
42.

Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease.

Kreijne JE, van der Giessen J, Verhaar AP, Peppelenbosch MP, de Vries AC, van der Woude CJ, Fuhler GM.

J Clin Gastroenterol. 2019 May/Jun;53(5):395-397. doi: 10.1097/MCG.0000000000000952. No abstract available.

PMID:
29256991
43.

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease.

Nuij VJAA, Peppelenbosch MP, van der Woude CJ, Fuhler GM.

J Transl Med. 2017 Dec 11;15(1):248. doi: 10.1186/s12967-017-1355-9.

44.

Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus.

Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP.

J Crohns Colitis. 2018 Mar 28;12(4):408-418. doi: 10.1093/ecco-jcc/jjx161.

PMID:
29216349
45.

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease.

Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, d'Haens G, Hoentjen F, Hommes DW, de Jong DJ, Löwenberg M, Maljaars PWJ, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, Ponsioen CY, Stokkers PC, Verspaget HW, Visschedijk MC, van der Woude CJ, Dijkstra G, Weersma RK; Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC).

BMJ Open. 2017 Nov 8;7(11):e016695. doi: 10.1136/bmjopen-2017-016695.

46.

The Impact of Ethnicity and Country of Birth on Inflammatory Bowel Disease Phenotype: a Prospective Cohort Study.

Spekhorst LM, Severs M, de Boer NKH, Festen EAM, Fidder HH, Hoentjen F, Imhann F, de Jong DJ, van der Meulen-de Jong AE, Pierik MJ, van der Woude CJ, Dijkstra G, Ponsioen CY, Löwenberg M, Oldenburg B, Weersma RK; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2017 Dec 4;11(12):1463-1470. doi: 10.1093/ecco-jcc/jjx098.

PMID:
28981621
47.

Analysis of SHIP1 expression and activity in Crohn's disease patients.

Somasundaram R, Fernandes S, Deuring JJ, de Haar C, Kuipers EJ, Vogelaar L, Middleton FA, van der Woude CJ, Peppelenbosch MP, Kerr WG, Fuhler GM.

PLoS One. 2017 Aug 2;12(8):e0182308. doi: 10.1371/journal.pone.0182308. eCollection 2017.

48.

Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.

Eppinga H, Poortinga S, Thio HB, Nijsten TEC, Nuij VJAA, van der Woude CJ, Vodegel RM, Fuhler GM, Peppelenbosch MP.

Inflamm Bowel Dis. 2017 Oct;23(10):1783-1789. doi: 10.1097/MIB.0000000000001169.

PMID:
28617755
49.

Endoscopy for Inflammatory Bowel Disease During Pregnancy: Only When There Is a Strong Indication.

Kanis SL, van der Woude CJ.

Gastroenterology. 2017 Jul;153(1):330-331. doi: 10.1053/j.gastro.2016.12.054. Epub 2017 Jun 1. No abstract available.

PMID:
28579272
50.

Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters.

Vogelaar L, de Haar C, Aerts BR, Peppelenbosch MP, Timman R, Hanssen BE, van der Woude CJ.

Clin Exp Gastroenterol. 2017 May 2;10:83-90. doi: 10.2147/CEG.S123942. eCollection 2017.

Supplemental Content

Loading ...
Support Center